These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22612288)

  • 1. Antivirals targeting influenza A virus.
    Das K
    J Med Chem; 2012 Jul; 55(14):6263-77. PubMed ID: 22612288
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the Potential of GANs in Biological Sequence Analysis.
    Murad T; Ali S; Patterson M
    Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Application of Computer-Aided Drug Design in Anti-Influenza A Virus Drug Discovery.
    Yu D; Wang L; Wang Y
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel
    Liang S; Ma X; Li M; Yi Y; Gao Q; Zhang Y; Zhang L; Zhou D; Xiao S
    Front Chem; 2022; 10():836955. PubMed ID: 35494649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-viral triterpenes: a review.
    Darshani P; Sen Sarma S; Srivastava AK; Baishya R; Kumar D
    Phytochem Rev; 2022; 21(6):1761-1842. PubMed ID: 35283698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isatin derivatives as broad-spectrum antiviral agents: the current landscape.
    Elsaman T; Mohamed MS; Eltayib EM; Abdel-Aziz HA; Abdalla AE; Munir MU; Mohamed MA
    Med Chem Res; 2022; 31(2):244-273. PubMed ID: 35039740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-influenza A virus activity and structure-activity relationship of a series of nitrobenzoxadiazole derivatives.
    Fiorentino F; De Angelis M; Menna M; Rovere A; Caccuri AM; D'Acunzo F; Palamara AT; Nencioni L; Rotili D; Mai A
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2128-2138. PubMed ID: 34583607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design.
    Mtambo SE; Amoako DG; Somboro AM; Agoni C; Lawal MM; Gumede NS; Khan RB; Kumalo HM
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox control in the pathophysiology of influenza virus infection.
    Chen KK; Minakuchi M; Wuputra K; Ku CC; Pan JB; Kuo KK; Lin YC; Saito S; Lin CS; Yokoyama KK
    BMC Microbiol; 2020 Jul; 20(1):214. PubMed ID: 32689931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of effective anti-influenza drugs: congeners and conjugates - a review.
    Shie JJ; Fang JM
    J Biomed Sci; 2019 Oct; 26(1):84. PubMed ID: 31640786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
    Yu Y; Tazeem ; Xu Z; Du L; Jin M; Dong C; Zhou HB; Wu S
    Medchemcomm; 2019 Jan; 10(1):89-100. PubMed ID: 31559005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Biological Evaluation of EdAP, a 4'-Ethynyl-2'-Deoxyadenosine 5'-Monophosphate Analog, as a Potent Influenza a Inhibitor.
    Takeuchi T; Sriwilaijaroen N; Sakuraba A; Hayashi E; Kamisuki S; Suzuki Y; Ohrui H; Sugawara F
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31319565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of
    Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Kadam RU; Wilson IA
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4240-4245. PubMed ID: 29610325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Simple Platform for the Rapid Development of Antimicrobials.
    Johnston SA; Domenyuk V; Gupta N; Batista MT; Lainson JC; Zhao ZG; Lusk JF; Loskutov A; Cichacz Z; Stafford P; Legutki JB; Diehnelt CW
    Sci Rep; 2017 Dec; 7(1):17610. PubMed ID: 29242618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1.
    Yin J; Ma L; Wang H; Yan H; Hu J; Jiang W; Li Y
    Acta Pharm Sin B; 2017 Nov; 7(6):630-637. PubMed ID: 29159022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
    Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
    Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.
    Hu Y; Sneyd H; Dekant R; Wang J
    Curr Top Med Chem; 2017; 17(20):2271-2285. PubMed ID: 28240183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis.
    Te Velthuis AJ; Fodor E
    Nat Rev Microbiol; 2016 Aug; 14(8):479-93. PubMed ID: 27396566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphylla saponin I has antiviral activity against influenza A virus.
    Pu X; Ren J; Ma X; Liu L; Yu S; Li X; Li H
    Int J Clin Exp Med; 2015; 8(10):18963-71. PubMed ID: 26770521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.